研究方案:制定、传播与实施单绒毛膜双胎妊娠选择性胎儿生长受限的核心结局指标集
本方案旨在为单绒毛膜双胎妊娠选择性胎儿生长受限的研究制定核心结局指标集。方法包括系统综述、三轮德尔菲调查和改良名义群体技术,由国际指导组监督,遵循COMET手册。最终将建立标准化定义和推荐高质量测量工具,以规范未来研究并改善临床实践。
要点
- 核心结局指标集将规范单绒毛膜双胎选择性胎儿生长受限研究的结局选择与报告。
- 制定过程包括系统综述、三轮德尔菲调查和改良名义群体技术。
- 将建立标准化定义并推荐高质量测量工具,以促进数据合成和临床实践。
核心结论
- 制定、传播和实施核心结局指标集应确保未来研究方案以标准化方式选择、收集和报告结局及结局测量。
- 数据合成将在广泛层面成为可能,严格实施应提升研究质量及其有效利用,以指导临床实践并改善患者护理、孕产妇、短期围产期结局和长期神经发育结局。
研究设计与样本
- 已成立包括专业人员、研究人员和非专业专家的国际指导组监督核心结局指标集的制定。
- 方法遵循COMET(Core Outcome Measures in Effectiveness Trials)倡议手册指导。
- 通过系统综述评估单绒毛膜双胎妊娠选择性胎儿生长受限干预措施的研究来开发潜在核心结局。
- 潜在核心结局将进入三轮德尔菲调查,邀请临床专业人员、研究人员和非专业专家等关键利益相关者参与。
- 对个体结局的反复反思和重新评分应鼓励群体和个体利益相关者向共识结局收敛,共识结局将进入改良名义群体技术以最终确定核心结局指标集。
关键数值与推荐
- COMET注册号:998。
- PROSPERO注册号:CRD42018092697,注册日期2018年4月18日。
临床怎么用
- 未来研究方案应标准化选择、收集和报告单绒毛膜双胎妊娠选择性胎儿生长受限的结局及结局测量。
- 严格实施核心结局指标集应提升研究质量及其有效利用,以指导临床实践并改善患者护理、孕产妇、短期围产期结局和长期神经发育结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Selective fetal growth restriction in monochorionic twin pregnancies is associated with an increased risk of perinatal mortality and morbidity and represents a clinical dilemma. Interventions include expectant management with early preterm delivery if there are signs of fetal compromise, selective termination of the compromised twin, fetoscopic laser coagulation of the communicating placental vessels or termination of the whole pregnancy. Previous studies evaluating interventions have reported many different outcomes and outcome measures. Such variation makes comparing, contrasting, and combining results challenging, limiting ongoing research on this uncommon condition to inform clinical practice. We aim to produce, disseminate, and implement a core outcome set for selective fetal growth restriction research in monochorionic twin pregnancies. METHODS: An international steering group, including professionals, researchers, and lay experts, has been established to oversee the development of this core outcome set. The methods have been guided by the Core Outcome Measures in Effectiveness Trials Initiative Handbook. Potential core outcomes will be developed by undertaking a systematic review of studies evaluating interventions for selective fetal growth restriction in monochorionic twin pregnancies. Potential core outcomes will be entered into a three-round Delphi survey and key stakeholders including clinical professionals, researchers, and lay experts will be invited to participate. Repeated reflection and rescoring of individual outcomes should encourage group and individual stakeholder convergence towards consensus outcomes which will be entered into a modified Nominal Group Technique to finalize the core outcome set. Once core outcomes have been agreed, we will establish standardized definitions and recommend high-quality measurement instruments for each outcome. DISCUSSION: The development, dissemination, and implementation of a core outcome set for selective fetal growth restriction should ensure that future research protocols select, collect, and report outcomes and outcome measures in a standardized manner. Data synthesis will be possible on a broad level and rigorous implementation should advance the quality of research studies and their effective use in order to guide clinical practice, improve patient care, maternal, short-term perinatal outcomes, and long-term neurodevelopmental outcomes. TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials (COMET) registration number: 998. International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42018092697 . 18th April 2018.
引用
- Khalil A, Duffy JMN, Perry H, et al. Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies. Trials. 2019. PMID: 30626413. doi:10.1186/s13063-018-3153-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。